• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 1.03% Nasdaq Up 1.29%

    Novogen Limited (NVGN)

    -NasdaqCM
    5.83 Up 0.27(4.86%) May 1, 4:00PM EDT
    Add to Portfolio
    Prev Close:5.56
    Open:5.60
    Bid:5.89 x 200
    Ask:6.20 x 2200
    1y Target Est:N/A
    Beta:-1.99
    Next Earnings Date:N/A
    Day's Range:5.60 - 6.17
    52wk Range:1.51 - 9.50
    Volume:452,884
    Avg Vol (3m):1,220,400
    Market Cap:58.30M
    P/E (ttm):N/A
    EPS (ttm):-0.75
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):36.25
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (0-00-31) :N/A
    Quarterly EPS Est (0-00-31) :N/A
    Mean Recommendation*:N/A
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Novogen Limited is engaged in the pharmaceutical research and development business in Australia. The company has primarily two drug technology platforms, which include super-benzopyrans (SBPs) and anti-tropomyosins (ATMs). View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback